We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
-0.85%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$15.5B
AUM Growth
+$465M
Cap. Flow
+$685M
Cap. Flow %
4.42%
Top 10 Hldgs %
22.16%
Holding
2,692
New
671
Increased
625
Reduced
715
Closed
596

Top Buys

Rank Stock Value
1
IVV icon
iShares Core S&P 500 ETF
IVV
+$1.07B
2
INDA icon
iShares MSCI India ETF
INDA
+$125M
3
CSX icon
CSX Corp
CSX
+$73.9M
4
CHRW icon
C.H. Robinson
CHRW
+$71.1M
5
AAPL icon
Apple
AAPL
+$70.5M

Sector Composition

Rank Sector Weight
1 Industrials 14.37%
2 Technology 11.84%
3 Consumer Discretionary 8.59%
4 Healthcare 7.01%
5 Financials 6.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HNST icon
2326
The Honest Company
HNST
$428M
-93,810
Closed -$380K
HR icon
2327
Healthcare Realty
HR
$7.02B
-596,545
Closed -$8.44M
HRTG icon
2328
Heritage Insurance Holdings
HRTG
$902M
-40,686
Closed -$433K
HSBC icon
2329
HSBC
HSBC
$364B
-92,937
Closed -$3.66M
HTGC icon
2330
Hercules Capital
HTGC
$3.16B
-55,600
Closed -$1.03M
HTHT icon
2331
Huazhu Hotels Group
HTHT
$13B
-56,700
Closed -$2.19M
HTLD icon
2332
Heartland Express
HTLD
$990M
-97,850
Closed -$1.17M
HYD icon
2333
VanEck High Yield Muni ETF
HYD
$4.44B
-13,064
Closed -$683K
PPLI
2334
People Inc
PPLI
$3.45B
-17,004
Closed -$744K
IART icon
2335
Integra LifeSciences
IART
$1.39B
-10,683
Closed -$379K
IDA icon
2336
Idacorp
IDA
$8.36B
-3,414
Closed -$317K
IDYA icon
2337
IDEAYA Biosciences
IDYA
$3.48B
-23,354
Closed -$1.02M
BRSL
2338
CALL
Brightstar Lottery PLC
BRSL
$2.08B
-75,000
Closed -$1.69M
ILPT
2339
Industrial Logistics Properties Trust
ILPT
$579M
-62,694
Closed -$269K
IMXI icon
2340
International Money Express
IMXI
$370M
-10,400
Closed -$237K
INSP icon
2341
Inspire Medical Systems
INSP
$1.85B
-63,125
Closed -$13.6M
INTC icon
2342
CALL
Intel
INTC
$509B
-100,000
Closed -$4.42M
INTC icon
2343
PUT
Intel
INTC
$509B
-212,500
Closed -$9.39M
INVE icon
2344
Identive
INVE
$64.3M
-10,999
Closed -$87.1K
INZY
2345
DELISTED
Inozyme Pharma
INZY
-74,800
Closed -$573K
IOVA icon
2346
Iovance Biotherapeutics
IOVA
$1.95B
-244,447
Closed -$3.62M
IPGP icon
2347
IPG Photonics
IPGP
$3.99B
-13,786
Closed -$1.25M
IPSC icon
2348
Century Therapeutics
IPSC
$363M
-93,085
Closed -$389K
IRT icon
2349
Independence Realty Trust
IRT
$4.02B
-36,100
Closed -$582K
ISPC icon
2350
iSpecimen
ISPC
$3.09M
-19
Closed -$3.53K

Similar funds

Schonfeld Strategic Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Schonfeld Strategic Advisors held 2,692 positions worth $15.5B, up 3.1% from $15B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Schonfeld Strategic Advisors deployed $685M of net new capital in Q2 2024, opening 671 new positions and adding to 625 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 2,042,404 shares worth $1.12B.

By sector, the portfolio is most concentrated in Industrials at 14% of assets, up from 13% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $753M trimmed.

  • Schonfeld Strategic Advisors's largest Q2 2024 buy was iShares Core S&P 500 ETF: 2,042,404 shares worth $1.12B.
  • Schonfeld Strategic Advisors added most to CSX Corp in Q2 2024, an estimated $73.9M increase.
  • Schonfeld Strategic Advisors's biggest Q2 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $753M.
  • Schonfeld Strategic Advisors fully exited iShares TIPS Bond ETF in Q2 2024, selling an estimated $41.9M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 22% of its $15.5B portfolio in Q2 2024.
  • Schonfeld Strategic Advisors opened 671 new positions and closed 596 in Q2 2024.
  • Schonfeld Strategic Advisors's portfolio value rose 3.1% quarter-over-quarter to $15.5B.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2024, filed 14 Aug 2024.